UPDATE : Monday, September 7, 2020
상단여백
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs by Kim Yun-mi 2019-02-12 15:56
Gilead’s hepatitis B drug posts disappointing sales in 2018 by Kim Yun-mi 2019-02-11 15:29
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018 by Kim Yun-mi 2019-02-11 14:35
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea by Kim Yun-mi 2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines by Kim Yun-mi 2019-02-08 12:02
라인
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales by Kim Yun-mi 2019-02-07 14:40
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease by Kim Yun-mi 2019-02-01 17:02
‘Alunbrig works better for ALK-positive non-small cell lung cancer’ by Kim Yun-mi 2019-02-01 15:38
Pfizer’s lung cancer drug Xalkori threatened by new rivals by Kim Yun-mi 2019-01-30 12:34
-이전1112131415-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top